StockWatch
·
Pharmaceuticals
Board Meeting5 Nov 2026, 11:18 am

Hester Biosciences Approves Q2 & H1 FY27 Results, USD 1M Loan

AI Summary

Hester Biosciences Limited announced its unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The Board of Directors also approved an unsecured loan of USD 1 million to its wholly-owned subsidiary, Hester Biosciences Africa Limited, for business and general corporate purposes, including working capital requirements. The loan has a tenure of three years with an interest rate of 9% per annum. The transaction is considered a related party transaction but is exempted under Regulation 23(5)(b) of the Listing Regulations and is conducted on an arm's length basis.

Key Highlights

  • Board approved Q2 & H1 FY27 unaudited financial results.
  • USD 1 million unsecured loan approved for Hester Africa.
  • Loan to subsidiary for business and working capital needs.
  • Loan carries 9% interest and a 3-year tenure.
  • Transaction is an arm's length related party transaction.